CRYO-VACC LAUNCHES IN SOUTH AFRICA WITH WORKING PROTOTYPE

Helium and natural gas company Renergen is proud to announce the completion and successful operation of the Company’s first Cryo-VaccTM prototype, which is being presented to South African based media at its headquarters in Johannesburg, today at 10am SAST.

Cryo-VaccTM was designed and patented by Renergen for efficient transport and storage of ultracold biologics for periods of up to 25 days or longer in transit, where access to an external power source is not possible. The Cryo-VaccTM has a temperature range of -150 ºC to 8ºC, making it highly versatile for a range of vaccines.

Combined with best-in-class cold chain monitoring and asset tracking technology from Beyond Wireless Proprietary Limited (“Beyond”), a World Health Organisation Performance, Quality and Safety (PQS) certified remote temperature monitoring solution provider, the Cryo-VaccTM can provide accurate temperature readings of the vaccines whilst in transit, as well as GPS tracking to ensure the custody chain can be audited.